| 期 |
标题 |
文件 |
| 卷 17, 编号 1 (2025) |
Analysis of demographic, clinical and laboratory parameters in COVID-19 patients with acute kidney injury |
|
|
Abdurakhimov A.
|
| 卷 15, 编号 4 (2023) |
Analysis of functional results of surgical treatment of kidney cancer |
|
|
Popov S., Guseynov R., Yesayan A., Sivak K., Perepelitsa V., Sadovnikova A., Grushevsky R., Lelyavina T.
|
| 卷 15, 编号 4 (2023) |
Arterial hypertension in kidney transplantation – modern therapy strategy |
|
|
Nosov V., Koroleva L., Solovyanova E.
|
| 卷 16, 编号 4 (2024) |
Biological significance of differentially expressed genes of hypoxic-ischemic acute kidney injury (part 2) |
|
|
Popov S., Guseinov R., Yesayan A., Isakova-Sivak I., Sivak K., Skryabin O., Gorbacheva I., Matveeva D., Grushevsky R., Kovalevskaya A., Beshtoev A., Malyshev E., Lelyavina T.
|
| 卷 16, 编号 2 (2024) |
Biological significance of differentially expressed genes in hypoxic-ischemic acute kidney injury |
|
|
Popov S., Guseinov R., Yesayan A., Skryabin O., Vasin A., Kovalevskaya A., Perepelitsa V., Beshtoev A., Lelyavina T.
|
| 卷 15, 编号 2 (2023) |
Castleman's disease associated with amyloidosis. Literature review and clinical observation |
|
|
Frolova N., Varyasin V., Volgina G., Sysoeva I., Mudarisov R., Usatyuk S., Dyakova E., Stolyarevich E.
|
| 卷 16, 编号 3 (2024) |
Effect of intensive therapy of acute renal failure on stroke output depending on age |
|
|
Mukhitdinova K., Mamatkulov B.
|
| 卷 16, 编号 3 (2024) |
The effect of optimization of diuretic therapy on kidney function during circulartory decompensation |
|
|
Abdullaev O., Vereshchak D., Dragunov D., Sokolova A., Rylova A., Arutyunov G.
|
| 卷 16, 编号 2 (2024) |
External validity of the international method for predicting clinical outcome of immunoglobulin A-nephropathy in the Belarusian cohort of patients |
|
|
Komissarov K., Krasko O., Pilotovich V., Dmitrieva M., Letkovskaya T., Prilutsky S.
|
| 卷 16, 编号 2 (2024) |
Mind the gap in kidney care: translating what we know into what we do |
|
|
Luyckx V., Tuttle K., Abdellatif D., Correa-Rotter R., Fung W., Haris A., Hsiao L., Khalife M., Kumaraswami L., Loud F., Raghavan V., Roumeliotis S., Sierra M., Ulasi I., Wang B., Lui S., Liakopoulos V., Balducci A.
|
| 卷 16, 编号 3 (2024) |
Age- and gender-related features of chronic kidney disease in residents of the Circopolar North |
|
|
Zhmurov V., Vanuito E., Zhmurov D., Oskolkov S., Petrova Y., Zhmurova E., Ermakova A., Ermakova P.
|
| 卷 16, 编号 1 (2024) |
Secondary hyperparathyroidism in patients with chronic kidney disease in Tyumen region: five-year follow-up data |
|
|
Avdeeva V., Syachina S., Eirich V., Zhmurov D., Zhmurov V.
|
| 卷 15, 编号 3 (2023) |
Choice of surgical tactics for calculous anuria in infants |
|
|
Nasirov A., Khotamov K., Baiakhmedov F., Khoshimov T.
|
| 卷 17, 编号 1 (2025) |
Gender differences in kidney function in COVID-19 |
|
|
Perepelitsa S.
|
| 卷 15, 编号 4 (2023) |
Genetic markers of thrombogenic risk in patients on program hemodialysis |
|
|
Voskresenskaya N., Orlova G., Romazina N.
|
| 卷 16, 编号 3 (2024) |
Glomerulonephritis in patients with previous coronavirus infection. Risks and consequences |
|
|
Polovikov I., Zakharova V., Sizova Z., Lapidus N., Shoikhet D., Lenkova N.
|
| 卷 15, 编号 3 (2023) |
Double-blind, randomized, phase I trial comparing the pharmacokinetics and safety of agalsidase beta bioanaloguer (Fabagal®) and the original drug (Fabrazim®) in healthy volunteers |
|
|
Moiseev S., Shchulkin A., Abalenikhina Y., Mylnikov P., Yakusheva E., Khmelevsky M., Macyak M.
|
| 卷 15, 编号 4 (2023) |
Diagnostic value of echocardiography parameters for assessing intravascular status in nephrotic syndrome in children |
|
|
Mamatkulov B., Mamatkulov I.
|
| 卷 15, 编号 2 (2023) |
Remote monitoring of renal transplant recipients |
|
|
Ivanova E., Kotenko O., Kargalskaya I., Vinogradov V., Berdinsky V., Artyukhina L., Frolova N.
|
| 卷 15, 编号 3 (2023) |
The significance of TNF-α in the pathogenesis of protein-energy malnutrition in patients on program hemodialysis |
|
|
Yakovenko A., Lavrishcheva Y., Rumyantsev A., Belskikh A.
|
| 卷 16, 编号 3 (2024) |
Difficulties in diagnosis and treatment of idiopathic cryoglobulinemic glomerulonephritis |
|
|
Grigoryeva E., Voloshinova E., Balkizova D., Myasnikova A.
|
| 卷 15, 编号 2 (2023) |
Intraoperative ultrasound navigation in minimally invasive organ-preserving treatment of renal cell carcinoma of a transplanted kidney |
|
|
Trushkin R., Isaev T., Medvedev P., Sokolov S., Morozov N., Parshin V., Son A., Klementyeva T.
|
| 卷 15, 编号 4 (2023) |
The use of modern MIS with elements of artificial intelligence in nephrology and precision renal replacement therapy |
|
|
Bolshakov S., Shutov E., Dolidze D., Sorokoletov S.
|
| 卷 16, 编号 4 (2024) |
History of the anatomy of the urinary system |
|
|
Subotialov M., Subotialova A.
|
| 卷 16, 编号 1 (2024) |
Quality of life in diabetic patients with chronic kidney disease |
|
|
Butranova O., Zyryanov S.
|
| 卷 15, 编号 3 (2023) |
Intestinal fatty acid binding protein as biomarker of enterocyte injury in patients with renal failure |
|
|
Pyatchenkov M., Sherbakov E., Trandina A., Belskykh A.
|
| 卷 15, 编号 1 (2023) |
Clinical and functional characteristics of mineral and bone disorders in chronic kidney disease |
|
|
Murkamilov I., Fomin V., Murkamilova Z., Sabirova A., Sabirov I., Yusupov F., Maanaev T., Zakirov O., Gasanov K.
|
| 卷 15, 编号 1 (2023) |
Clinical evaluation of uropathogen selection in vivo |
|
|
Berdichevsky V., Berdichevsky B., Sapozhenkova E., Pavlova I., Gonyaev A., Boldyrev A., Korabelnikov M., Petrov D., Spirina D.
|
| 卷 17, 编号 1 (2025) |
Clinical cases of acute kidney injury under conditions of exposure to short-term abnormal heat waves |
|
|
Murkamilov I., Aitbaev K., Fomin V., Yusupov F., Yusupova T., Yusupova Z., Duysheeva G., Khakimov S., Solizhonov Z., Ymankulov D.
|
| 卷 16, 编号 3 (2024) |
Clinical case of severe recurrent campylobacteriosis in a patient - renal transplant recipient |
|
|
Iskhakov R., Frolova N., Arbolishvili G., Kuzmenko M., Artyukhina L., Andreev S., Kobzar M., Frolov A.
|
| 卷 16, 编号 3 (2024) |
Clinical case of successful treatment of granulomatosis with polyangiitis |
|
|
Frolova N., Mutovina Z., Kobzar M., Arbolishvili G., Pavlov D., Shmeleva D., Manerov F., Lysenko M.
|
| 卷 16, 编号 4 (2024) |
Hemostasis system markers (coagulation factors) and left ventricle geometry in proteinuric variants of chronic kidney disease |
|
|
Murkamilov I., Aitbaev K., Fomin V., Yusupov F., Yusupova T., Yusupova Z., Duysheeva G., Khakimov S., Solizhonov Z., Ymankulov D.
|
| 卷 15, 编号 1 (2023) |
Methods of nutrition therapy of patients with chronic kidney disease |
|
|
Mikhailova N.
|
| 卷 15, 编号 2 (2023) |
Mechanisms of albumin loss against the background of the use of modern methods of renal replacement therapy |
|
|
Litvinov A., Gasanov M., Kuznetsova Y., Gergia S., Shevchenko S.
|
| 卷 15, 编号 4 (2023) |
Myostatin is an important link in the pathogenesis of protein-energy deficiency in patients on program hemodialysis |
|
|
Yakovenko A., Yesayan A., Lavrishcheva Y., Rumyantsev A.
|
| 卷 16, 编号 4 (2024) |
Multifactorial kidney damage in a comorbid patient |
|
|
Yumasheva V., Komarova I., Rachina S., Mayorov V., Melnik D., Mirzakhamidova S.
|
| 卷 16, 编号 4 (2024) |
Morphological structure of late kidney transplant dysfunction |
|
|
Rapetskaya N., Komissarov K., Dmitrieva M., Liatkoyskaya T., Kalachyk A.
|
| 卷 16, 编号 2 (2024) |
Morphological features of polycystic kidney in acute renal artery occlusion |
|
|
Trushkin R., Medvedev P., Lagoyskaya Y., Fettser D., Klementieva T.
|
| 卷 16, 编号 1 (2024) |
Nephrogenic anemia in patients receiving renal replacement therapy, pathogenesis and resistance |
|
|
Ryasnyansky V., Shostka G., Anikonova L.
|
| 卷 15, 编号 3 (2023) |
Nephrological service of the Russian Federation 2022: post-covid period. Clinical nephrology |
|
|
Shilov E., Shilova M., Rumyantseva E., Batyushin M., Bevzenko A., Belskikh A., Veselkova N., Yesayan A., Ivliev S., Kotenko O., Petrova N., Statsenko M., Stolyar A.
|
| 卷 16, 编号 1 (2024) |
Nephrological service of the Russian Federation 2023: Part I. Renal Replacement Therapy |
|
|
Shilov E., Shilova M., Rumyantseva E., Batyushin M., Bevzenko A., Belskikh A., Veselkova N., Yesayan A., Ivliev S., Kotenko O., Petrova N., Statsenko M., Stolyar A.
|
| 卷 16, 编号 4 (2024) |
Nephrological service of the Russian Federation 2023: Part II. Resources and staff |
|
|
Shilov E., Shilova M., Rumyantseva E., Batyushin M., Bevzenko A., Belskikh A., Veselkova N., Yesayan A., Ivliev S., Kotenko O., Petrova N., Statsenko M., Stolyar A.
|
| 卷 17, 编号 1 (2025) |
Nephrology service of the Russian Federation 2024: Part I. Renal replacement therapy |
|
|
Shilov E., Shilova M., Rumyantseva E., Batyushin M., Bevzenko A., Belskikh A., Veselkova N., Yesayan A., Ivliev S., Kotenko O., Petrova N., Statsenko M., Stolyar A.
|
| 卷 15, 编号 2 (2023) |
Experience with the use of eculizumab in the treatment of thrombotic microangiopathy in a patient with systemic lupus erythematosus |
|
|
Chuev N., Frolova N., Iskhakov R., Usatyuk S., Terentyeva N.
|
| 卷 15, 编号 2 (2023) |
Features of kidney damage in metabolic syndrome |
|
|
Vorotylov A., Mikhailova Z.
|
| 卷 16, 编号 1 (2024) |
Features of the course and the prognosis in patients with multiple myeloma depending on the renal involvement |
|
|
Grigoryan Z., Marchenko Y., Khachatryan M.
|
| 卷 16, 编号 2 (2024) |
Features of the course of chronic kidney disease and left ventricle geometry in women and men at the pre-dialysis stage of the disease |
|
|
Murkamilov I., Aitbaev K., Fomin V., Yusupova T., Duysheeva G., Yusupov F.
|
| 卷 17, 编号 1 (2025) |
Acute kidney damage due to statin taken: case description and literature review |
|
|
Zubeev P., Kharlamova O., Motylev I., Zubeeva G., Suslova O., Shilov E.
|
| 卷 17, 编号 1 (2025) |
Acute kidney injury in patients with COVID-19: severity of inflammatory response and risk of chronic kidney disease development |
|
|
Mikhailova L., Perepelitsa S., Struchkov S., Orlova Y., Akchurina K.
|
| 卷 15, 编号 3 (2023) |
Acute tubulointerstitial nephritis of medicinal etiology: the focus is on antibacterial drugs |
|
|
Murkamilov I., Fomin V., Sabirov I., Yusupov F., Satkynalieva Z.
|
| 卷 16, 编号 3 (2024) |
Evaluation of the efficiency of nephroprotective therapy in patients with chronic kidney disease and arterial hypertension |
|
|
Zhmurov V., Ermakova P., Ermakova A., Zhmurov D., Vanuyto E.
|
| 卷 15, 编号 4 (2023) |
In memory of Lovchinsky Evgeny Valentinovich |
|
|
Editorial B.
|
| 卷 16, 编号 1 (2024) |
The first case of successful pregnancy and natural childbirth in a patient on program hemodialysis in Uzbekistan |
|
|
Daminov B., Azizov S., Sharapov O., Safoeva S.
|
| 卷 16, 编号 4 (2024) |
Personalization of renal replacement therapy and its effect on survival of patients with stage 5 chronic kidney disease aged 60 and older |
|
|
Kurylovich K., Komissarov K., Krasko O., Kamisarau S., Ilyinchyk A., Prylutski S., Zhaholkin Y.
|
| 卷 16, 编号 4 (2024) |
Prospects for using the qrisk3 risk scale in patients with chronic kidney disease and sarcopenia |
|
|
Sokolova A., Stafeeva E., Stafeev A., Dragunov D., Arutyunov G.
|
| 卷 17, 编号 1 (2025) |
HIF-prolylhydroxylase inhibitors: the future for anemia treatment in patients with chronic kidney disease |
|
|
Levchenkova O., Novikov V., Vorobyova V., Kozlov S.
|
| 卷 16, 编号 3 (2024) |
Improving the health literacy of patients with ckd. Informed choice and collaborative decision making. further patient education when choosing a peritoneal dialysis method |
|
|
Berdinsky V., Kotenko O., Frolova N., Vinogradov V., Kargalskaya I., Ivanova E., Dorofeeva E.
|
| 卷 15, 编号 4 (2023) |
Post-contrast acute kidney injury: definition, prevalence and risk factors |
|
|
Sabirov I., Murkamilov I., Fomin V.
|
| 卷 15, 编号 4 (2023) |
Posttransfusion hemochromatosis and cardiorenal syndrome. Local register data |
|
|
Matveev M., Mikhailova Z.
|
| 卷 17, 编号 1 (2025) |
Right ventricle, pulmonary pressure and their relationship with renal function in patients with overweight and obesity |
|
|
Murkamilov I., Aitbaev K., Fomin V., Yusupov F., Yusupova T., Yusupova Z., Duysheeva G., Khakimov S., Abdurakhmanov I., Solizhonov Z., Ymankulov D., Khabibullaev K.
|
| 卷 17, 编号 1 (2025) |
Predictors of fatal outcome in patients hospitalized for graft pyelonephritis |
|
|
Andreev S., Trushkin R., Isaev T., Artyukhina L., Frolova N., Ilyukhina N., Narusova P., Abdullaev S., Dushkin A., Lysenko M., Zhuravleva M.
|
| 卷 15, 编号 3 (2023) |
The use of bilateral total transarterial kidney embolization for the combined treatment of patients with symptomatic autosodominant polycystic kidney disease and end-stage renal disease |
|
|
Vtorenko V., Trushkin R., Medvedev P., Vinogradov V., Isaev T., Sokolov S., Bondarenko S., Kolesnikov N., Ivanov K.
|
| 卷 15, 编号 1 (2023) |
Interleukin-6 receptor inhibitor levilimab in the treatment of COVID-19 in patients with chronic kidney disease |
|
|
Frolova N., Tomilina N., Usatyuk S., Dyakova E., Sysoeva I., Terentyeva N., Frolov M., Kim I.
|
| 卷 16, 编号 1 (2024) |
Application of kidney injury molecule-1 (KIM-1) for predicting urgent cardiovascular complications in acute cardiorenal syndrome |
|
|
Pivovarov D., Mikhailova Z.
|
| 卷 16, 编号 4 (2024) |
Application of the anolit in the prevention of peritoneal dialysis catheter-associated infections |
|
|
Berdinsky V., Kotenko O., Frolova N., Kargalskaya I., Ushakova A., Orlova A., Kozlov I., Suvorov O.
|
| 卷 15, 编号 1 (2023) |
Pro-inflammatory cytokines and their participation in the development of cardiovascular calcification in patients with chronic kidney disease |
|
|
Mambetova A., Khutueva M., Tkhabisimova I.
|
| 卷 16, 编号 1 (2024) |
Prognostic value of the Charlson comorbidity index in patients aged 60 years and older starting chronic dialysis treatment |
|
|
Kurylovich K., Komissarov K., Krasko O.
|
| 卷 15, 编号 3 (2023) |
Development of ideas about urolithiasis |
|
|
Subotyalov M.
|
| 卷 15, 编号 1 (2023) |
Early predictors of kidney damage in children and adolescents with type 1 diabetes mellitus |
|
|
Zeinebekova A., Umarova A., Usmanova D., Turkara A., Kovalchuk V., Dyussenova S.
|
| 卷 16, 编号 3 (2024) |
Prevalence and diagnosis of autosomal dominant polycystic kidney disease |
|
|
Dzhalilzoda S.
|
| 卷 17, 编号 1 (2025) |
Prevalence and pathogenesis of kidney damage in non-alcoholic fatty liver disease – possibilities of early diagnostics using fluorescence organoscopy |
|
|
Lelyavina T., Galagudza M., Sonin D., Popov S., Guseinov R., Beshtoev A., Malyshev E.
|
| 卷 15, 编号 3 (2023) |
Prevalence of sarcopenia in patients with chronic heart failure and chronic kidney disease |
|
|
Sokolova A., Dragunov D., Arutyunov G.
|
| 卷 15, 编号 2 (2023) |
Regional citrate anticoagulation with 4% sodium citrate |
|
|
Avetisyan E., Kostritsa N.
|
| 卷 15, 编号 2 (2023) |
Rare benign kidney tumors. Review of clinical cases |
|
|
Trushkin R., Isaev T., Medvedev P., Sokolov S., Parshin V., Manchenko O., Varyasin V., Berezhnaya E., Klementyeva T.
|
| 卷 15, 编号 3 (2023) |
The burden of COVID-19 in a heterogeneous population of immunocompromised patients – realities of the postpandemic. Terapevticheskii Arkhiv (Ter. Arkh.) |
|
|
Avdeev S., Chulanov V., Alekseeva E., Alyoshina O., Bereznikov A., Kotenko O., Lila A., Mutovina Z., Parovichnikova E., Fomina D., Frolova N., Shevchenko A.
|
| 卷 16, 编号 2 (2024) |
The results of a multifactorial analysis to identify medical and social factors associated with the quality of life of patients with chronic kidney disease on hemodialysis |
|
|
Kotenko O., Abolyan L., Kuteinikov V., Arsanukaev I., Dorofeeeva E., Vinogradov V.
|
| 卷 16, 编号 3 (2024) |
ISPD guidelines on catheter-associated infections 2023 |
|
|
Chow K., Li P., Cho Y., Abu-Alfa A., Bavanandan S., Brown E., Cullis B., Edwards D., Ethier I., Hurst H., Ito Y., Proenc´a de Moraes T., Morelle J., Runnegar N., Saxena A., So S., Tian N., Johnson D.
|
| 卷 16, 编号 2 (2024) |
Roxadustat: treatment of anemia and additional clinical effects (literature review) |
|
|
Mikhailova N.
|
| 卷 15, 编号 4 (2023) |
Systematic review and meta-analysis of the effect of calcineurin inhibitors on long-term prognosis in kidney transplant recipients |
|
|
Novikova M., Minushkina L., Kotenko O., Zateyshchikov D., Boeva O., Allazova S., Shilov E.
|
| 卷 16, 编号 1 (2024) |
Screening for sarcopenia in patients with chronic heart failure and chronic kidney disease |
|
|
Sokolova A., Dragunov D., Arutyunov G.
|
| 卷 15, 编号 1 (2023) |
Mortality among kidney transplant recipients with SARS-CoV-2: a systematic review and meta-analysis of cohorts and clinical registries |
|
|
Novikova M., Minushkina L., Kotenko O., Zateyshchikov D., Boeva O., Allazova S., Shilov E., Koteshkova O., Antsiferov M.
|
| 卷 15, 编号 1 (2023) |
Mortality in kidney transplant recipients: a systematic review and meta-analysis of cohorts and clinical registries |
|
|
Novikova M., Minushkina L., Kotenko O., Zateyshchikov D., Boeva O., Allazova S., Shilov E.
|
| 卷 16, 编号 1 (2024) |
Modern concepts of the role of asymptomatic hyperuricemia in the formation of chronic kidney disease and cardiovascular risk |
|
|
Dudnikova A., Mekhrabov R., Alieva A., Gish Z., Leontyev A., Rasskazova D.
|
| 卷 16, 编号 3 (2024) |
Current trends in requirements for a donor organ in kidney transplantation |
|
|
Trushkin R., Medvedev P., Sokolov S., Shcheglov N., Sokolov A.
|
| 卷 16, 编号 3 (2024) |
Relationship of the concepts “medical service” and “medical care” |
|
|
Lipatnikova V.
|
| 卷 16, 编号 2 (2024) |
Combined congenital anomaly of the bladder and urethra in a child. Possibilities of surgical treatment |
|
|
Morozov S., Kursova T., Podgorny A., Polishchuk L., Grigoryan L., Piruzieva O., Petukhova E.
|
| 卷 15, 编号 2 (2023) |
Method for surgical treatment of bladder cancer in patients with end-stage renal disease on renal replacement therapy with program hemodialysis simultaneously with treatment and prevention of purulent pyelonephritis. Review of clinical cases |
|
|
Trushkin R., Martov A., Sokolov S., Isaev T., Shcheglov N., Teikhrib P.
|
| 卷 15, 编号 1 (2023) |
Comparison of diagnostic significance of calculation of glomerular filtration rate based on creatinine and cystatin c in patients with chronic obstructive pulmonary disease |
|
|
Bolotova E., Dudnikova A.
|
| 卷 16, 编号 1 (2024) |
Comparative pharmacoeconomic analysis of the use of epoetin alfa and roxadustat in combination with iron supplements in adult patients with anemia against the background of chronic kidney disease in the healthcare system of the Russian Federation |
|
|
Krysanov I., Makarova E., Ermakova V., Kurkin D.
|
| 卷 15, 编号 2 (2023) |
Teleguidance of patients on ambulatory peritoneal dialysis using the "Telenefrocenter" platform for remote monitoring and rehabilitation |
|
|
Berdinsky V., Ivanova E., Kotenko O., Kargalskaya I., Vinogradov V., Frolova N.
|
| 卷 16, 编号 2 (2024) |
Treatment of dyslipidemia using inclisiran in a case series of patients after kidney and liver transplantation |
|
|
Kordonova O., Gubarev K., Frolova N., Svetlakova D., Voskanyan S., Artyukhina L.
|
| 卷 15, 编号 2 (2023) |
Thrombosis and embolism in patients with chronic kidney disease |
|
|
Murkamilov I., Fomin V., Sabirov I., Satkynalieva Z., Yusupov F.
|
| 卷 17, 编号 1 (2025) |
Thrombotic microangiopathies: differential diagnostics and choice of treatment strategy |
|
|
Vershinina A., Vershinin P.
|
| 卷 16, 编号 2 (2024) |
Difficulties in diagnosis and treatment of atypical hemolytic-uremic syndrome: clinical case |
|
|
Bakhareva Y., Chapaeva N.
|
| 卷 15, 编号 4 (2023) |
Difficulties in diagnosing and treating recurrent aHUS in a modern hospital setting |
|
|
Popov S., Yesayan A., Guseynov R., Perepelitsa V., Vorobyova O., Sadovnikova A.
|
| 卷 15, 编号 2 (2023) |
Difficulties in diagnosing microscopic polyangiitis |
|
|
Simonova O., Postnikova G., Stolyarevich E.
|
| 卷 16, 编号 4 (2024) |
Difficulties in the differential diagnosis of comorbid fluid and electrolyte balance disorders: description of a clinical case |
|
|
Pivovarov D., Mikhailova Z.
|
| 卷 15, 编号 1 (2023) |
Participation of fibroblast factor 23 in the development of acute myocardial infarction in patients with chronic kidney disease |
|
|
Mambetova A., Gaturaeva S., Semenova I.
|
| 卷 15, 编号 3 (2023) |
Formulas for estimating glomerular filtration rate: correct and incorrect use |
|
|
Shilov E.
|
| 卷 15, 编号 1 (2023) |
Chronic dialysis in elderly and senile patients: survival and factors affecting outcome. Single-center experience |
|
|
Kurilovich K., Komissarov K., Krasko O.
|
| 1 - 100 的 103 信息 |
1 2 > >> |
